Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/19/12 → 09/30/15 |
Funding
- Gilead Sciences Incorporated: $27,194.00
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects with a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention with Incomplete...
- Lawson, William (CoPI)
- Gruberg, Luis (PI)
- Chernilas, Joseph (CoPI)
- Jeremias, Allen (CoPI)
- Mani, Anil (CoPI)
Project: Research